1 Idle, J. R. & Gonzalez, F. J. Metabolomics.
2 Uppal, K. et al. Computational Metabolomics: A Framework for the Million Metabolome. Chem Res Toxicol 29, 1956-1975, doi:10.1021/acs.chemrestox.6b00179 (2016).
3 Jones, D. P. Sequencing the exposome: A call to action. Toxicol Rep 3, 29-45, doi:10.1016/j.toxrep.2015.11.009 (2016).
4 Jones, D. P. & Cohn, B. A. A vision for exposome epidemiology: The pregnancy exposome in relation to breast cancer in the Child Health and Development Studies.
5 Rappaport, S. M. Implications of the exposome for exposure science. Journal of Exposure Science & Environmental Epidemiology 21, 5-9, doi:10.1038/jes.2010.50 (2011).
6 Schymanski, E. L. et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol 48, 2097-2098, doi:10.1021/es5002105 (2014).
7 Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211-221, doi:10.1007/s11306-007-0082-2 (2007).
8 Walker, D. I. et al. Deployment-Associated Exposure Surveillance With High-Resolution Metabolomics. J Occup Environ Med 58, S12-21, doi:10.1097/JOM.0000000000000768 (2016).
9 Walker, D., Go, Y.-M., Liu, K., Pennell, K. & Jones, D. 167-211 (2016).
10 Djoumbou-Feunang, Y. et al. BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform 11, 2, doi:10.1186/s13321-018-0324-5 (2019).
11 Ruttkies, C., Schymanski, E. L., Wolf, S., Hollender, J. & Neumann, S. MetFrag relaunched: incorporating strategies beyond in silico fragmentation. J Cheminform 8, 3-3, doi:10.1186/s13321-016-0115-9 (2016).
12 Allen, F., Pon, A., Wilson, M., Greiner, R. & Wishart, D. CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra. Nucleic Acids Research 42, W94-W99, doi:10.1093/nar/gku436 (2014).
13 Djoumbou-Feunang, Y. et al. CFM-ID 3.0: Significantly Improved ESI-MS/MS Prediction and Compound Identification. Metabolites 9, doi:10.3390/metabo9040072 (2019).
14 Kolrep, F., Rein, K., Lampen, A. & Hessel-Pras, S. Metabolism of okadaic acid by NADPH-dependent enzymes present in human or rat liver S9 fractions results in different toxic effects.
15 Li, Y. et al. Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B 9, 1113-1144, doi:https://doi.org/10.1016/j.apsb.2019.10.001 (2019).
16 Rudolph, W., Remane, D., Wissenbach, D. K. & Peters, F. T. Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
17 Varkhede, N. R., Jhajra, S., Ahire, D. S. & Singh, S. Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using liquid chromatography with high-resolution mass spectrometry and multiple-stage mass spectrometry: Characterization of the diquinone metabolite supposedly responsible for the drug's hepatotoxicity. Rapid Communications in Mass Spectrometry 28, 311-331, doi:10.1002/rcm.6787 (2014).
18 Caspar, A. T., Meyer, M. R., Westphal, F., Weber, A. A. & Maurer, H. H. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
19 Singh, R., Chang, S. Y. & Taylor, L. C. E. In vitro Metabolism of a Potent HIV-protease Inhibitor (141W94) Using Rat, Monkey and Human Liver S9. Rapid Communications in Mass Spectrometry 10, 1019-1026, doi:10.1002/(sici)1097-0231(19960715)10:9<1019::Aid-rcm618>3.0.Co;2-j (1996).
20 Chalbot, S. & Morfin, R. Human liver S9 fractions: Metabolism of dehydroepiandrosterone, epiandrosterone, and related 7-hydroxylated derivatives. Drug Metabolism and Disposition 33, 563-569, doi:10.1124/dmd.104.003004 (2005).
21 Coles, R. & Kharasch, E. D. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes. Pharm Res 25, 1405-1411, doi:10.1007/s11095-008-9535-1 (2008).
22 Kind, T. & Fiehn, O. Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 7, 234, doi:10.1186/1471-2105-7-234 (2006).
23 Richardson Sj Fau - Bai, A., Bai A Fau - Kulkarni, A. A., Kulkarni Aa Fau - Moghaddam, M. F. & Moghaddam, M. F. Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability.
24 Peisl, B. Y. L., Schymanski, E. L. & Wilmes, P. Dark matter in host-microbiome metabolomics: Tackling the unknowns-A review. Anal Chim Acta 1037, 13-27, doi:10.1016/j.aca.2017.12.034 (2018).
25 Liu, K. H. et al. Reference Standardization for Quantification and Harmonization of Large-Scale Metabolomics. Analytical Chemistry, doi:10.1021/acs.analchem.0c00338 (2020).
26 Pluskal, T., Castillo, S., Villar-Briones, A. & Orešič, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11, 395, doi:10.1186/1471-2105-11-395 (2010).
27 Rask, K. J., Brigham Kl Fau - Johns, M. M. E. & Johns, M. M. Integrating comparative effectiveness research programs into predictive health: a unique role for academic health centers.
28 Brigham, K. L. Predictive health: the imminent revolution in health care. J Am Geriatr Soc 58 Suppl 2, S298-S302, doi:10.1111/j.1532-5415.2010.03107.x (2010).
29 Tabassum, R. et al. A Longitudinal Study of Health Improvement in the Atlanta CHDWB Wellness Cohort.
30 Yu, T. & Jones, D. P. Improving peak detection in high-resolution LC/MS metabolomics data using preexisting knowledge and machine learning approach.
31 Yu, T., Park, Y., Johnson, J. M. & Jones, D. P. apLCMS--adaptive processing of high-resolution LC/MS data. Bioinformatics (Oxford, England) 25, 1930-1936, doi:10.1093/bioinformatics/btp291 (2009).
32 Uppal, K. S., Q. A.; Strobel, F. H.; Pittard, W. S.; Gernert, K. M.; Yu, T.; Jones, D. P. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics 14, doi:10.1186/1471-2105-14-15 (2013).
33 Uppal, K., Ma, C., Go, Y. M., Jones, D. P. xMWAS: a data-driven integration and differential network analysis tool.